Genetic and epigenetic analysis of the putative tumor suppressor km23 in primary ovarian, breast, and colorectal cancers

Clinical Cancer Research

Volumn 12, Issue 12, 2006, Pages 3713-3715

  Campbell, Ian G ^a,b,c   Phillips, Wayne A ^b,c   Choong, David Y H ^a  

^a Victorian Breast Cancer Research Consortium   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; DNA; GENOMIC DNA; GROWTH HORMONE BINDING PROTEIN;

ARTICLE; BREAST CANCER; CARCINOGENICITY; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; EPIGENETICS; EXON; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GERM LINE; HUMAN; KM23 GENE; METHYLATION; MUCINOUS CARCINOMA; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DNA PRIMERS; DYNEIN ATPASE; FEMALE; GENE SILENCING; HUMANS; MUTATION; OVARIAN NEOPLASMS; PROMOTER REGIONS (GENETICS); TUMOR SUPPRESSOR PROTEINS;

EID: 33745697754     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0800     Document Type: Article

References (11)

1. Ding W, Tang Q, Espina V, et al. A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer. Cancer Res 2005;65:6526-33.
2. Campbell IG, Nicolai HM, Foulkes WD, et al. A novel gene encoding a B-Box protein within the BRCA1 region at 17q21.1. Hum Mol Genet 1994;3:589-94.
3. Dobrovic A, Bianco T, Tan LW, et al. Screening for and analysis of methylation differences using methylation-sensitive single-strand conformation analysis. Methods 2002;27:134-8.
4. Sutherland KD, Lindeman GJ, Wittlin S, et al. Differential silencing of SOCS genes by hypermethylation in breast and ovarian carcinomas. Oncogene 2004;23:7726-33.
5. Takai, D Jones PA. The CpG island searcher: a new WWW resource. In Silico Biol 2003;3:235-40.
6. Gross E, Arnold N, Goette J, et al. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet 1999;105:72-8.
7. Campbell IG, Russell SE, Choong DY, et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 2004;64:7678-81.
8. Sutherland KD, Visvader JE, Choong DYH, et al. Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas. Int J Cancer 2003;107:155-8.
9. Bryan EJ, Jokubaitis VJ, Chamberlain NL, et al. Mutation analysis of EP300 in colon, breast and ovarian carcinomas. Int J Cancer 2002;102:137-41.
10. Philp AJ, Campbell IG, Leet C, et al. The phosphatidylinositol 3′-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 2001;61:7426-9.
11. Foulkes WD, Stamp GW, Afzal S, et al. MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status. Br J Cancer 1995;72:883-8.